Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
118 hedge funds and large institutions have $1.12B invested in Myovant Sciences Ltd. in 2022 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 31 closing their positions.
120% more capital invested
Capital invested by funds: $511M → $1.12B (+$612M)
77% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 31
20% more funds holding
Funds holding: 98 → 118 (+20)
18% more call options, than puts
Call options by funds: $18.1M | Put options by funds: $15.3M
4% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$227M |
| 2 |
Goldman Sachs
New York
|
+$50.8M |
| 3 |
CC
Carlson Capital
Dallas,
Texas
|
+$47.5M |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$36.5M |
| 5 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
+$35.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$98.2M |
| 2 |
Janus Henderson Group
London,
|
-$73M |
| 3 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$35M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$22.9M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9.09M |
MYOV Hedge Fund Activity: Q4 2022 in Review
118 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q4 2022, worth a combined $1.12B — up 120% from $511M a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new MYOV positions and 31 closed out — a net gain of 24 holders — while 27 added to existing stakes and 26 trimmed.
The largest buyer was Fidelity International, opening a new position worth an estimated $227M. The largest seller was Wellington Management Group, exiting entirely with an estimated $98.2M sold.
- 118 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q4 2022, up from 98 in Q3 2022.
- Funds reported $1.12B of Myovant Sciences Ltd. stock for Q4 2022, up 120% quarter-over-quarter.
- 55 funds opened new Myovant Sciences Ltd. positions in Q4 2022 and 31 closed out, a net change of +24 holders.
- The largest Myovant Sciences Ltd. buyer in Q4 2022 was Fidelity International, an estimated $227M added.
- The largest Myovant Sciences Ltd. seller in Q4 2022 was Wellington Management Group, an estimated $98.2M sold.
Based on aggregated 13F filings for Q4 2022.